Curie Capital start nieuw seedfonds

Eindhoven, the Netherlands – January 19, 2026 –  Sirius Medical, the leader in surgical marker navigation, proudly announces...

Dutch life sciences VC BioGeneration Ventures led TargED’s €21.5 million Series A extension Proceeds will accelerate clinical...

- TGD001 was well tolerated with no dose-limiting toxicities across all dose cohorts, exhibiting potent thrombolytic activity -...

Financing co-led by Kurma Partners and Curie Capital, includes strong line-up of European investors  Matthew Baker appointed as...

 TargED Biopharmaceuticals B.V., a clinical-stage biotechnology company developing next-generation targeted treatments for...

Phase I trial data in rheumatoid arthritis patients demonstrates favorable safety, encouraging clinical activity, and robust...